-
DEVELOPMENT OF A DECISION MODEL FOR EVALUATING THE COST-EFFECTIVENESS OF HOME HEMODIALYSIS IN JAPAN
Aug 11, 2026, 17:16 PM -
LIMITED PROACTIVE MYELOPROTECTION IN EXTENSIVE-STAGE SMALL-CELL LUNG CANCER: REAL-WORLD PATTERNS OF G-CSF USE IN GERMAN STATUTORY HEALTH INSURANCE CLAIMS, 2010-2024
Aug 11, 2026, 17:16 PM -
REVIEW OF EVIDENCE UNDERPINNING RECOMMENDATIONS IN PAST NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE HEALTHTECH GUIDANCE
Aug 11, 2026, 17:16 PM -
FROM HAZARD RATIO TO CLINICAL IMPACT: NUMBER NEEDED TO TREAT IN PLATINUM-RESISTANT OVARIAN CANCER
Aug 11, 2026, 17:16 PM -
STRUCTURED REVIEW OF AN RWE PROTOCOL TEMPLATE IDENTIFIES UPSTREAM GAPS IN CAUSAL AND FRAMEWORK ALIGNMENT
Aug 11, 2026, 17:16 PM -
DIRECT MEDICAL COSTS OF BREAST CANCER BY SUBTYPE AND STAGE IN KOREA: A PATIENT-LEVEL RETROSPECTIVE COHORT ANALYSIS
Aug 11, 2026, 17:16 PM -
AN END-TO-END LLM PIPELINE FOR HEALTH ECONOMIC TECHNICAL REPORTS: RIGHTS-VERIFIED SOURCES, EXPERT-APPROVED DRAFTING, AND HALLUCINATION-FREE CITATIONS
Aug 11, 2026, 17:16 PM -
TREATMENT INTENSIFICATION PATTERNS BASED ON REAL-WORLD EVIDENCE FOR METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER BETWEEN 2012 AND 2025: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVIDENCE EXTERNAL CONTROL ARMS IN HTA SUBMISSIONS OF NEW ONCOLOGY AND RARE DISEASE THERAPIES: COVERAGE OUTCOMES AND APPRAISAL TIMELINES ACROSS NICE, CDA-AMC, AND PBAC (2020-2025)
Aug 11, 2026, 17:16 PM -
ANALYSIS OF TRANSPARENCY COMMISSION EVALUATIONS OF ADOLESCENT INDICATION EXTENSIONS IN RELATION TO CORRESPONDING ADULT EVALUATIONS IN FRANCE
Aug 11, 2026, 17:16 PM -
DECODING PECAN: WHAT EARLY FRENCH ASSESSMENTS REVEAL ABOUT MARKET ACCESS FOR DIGITAL MEDICAL DEVICES
Aug 11, 2026, 17:16 PM -
ADDRESSING IMMATURE OVERALL SURVIVAL DATA IN ONCOLOGY COST-EFFECTIVENESS MODELING: A TRIANGULATED FRAMEWORK FOR ROBUST EXTRAPOLATION
Aug 11, 2026, 17:16 PM -
SOCIOECONOMIC BURDEN OF TYPE 1 SMA IN JAPAN: COMPARING THE IMPACT OF ONASEMNOGENE ABEPARVOVEC, NUSINERSEN AND RISDIPLAM ON PATIENTS AND CAREGIVERS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF BEMPEDOIC ACID AS ADJUNCT TO STANDARD OF CARE (SOC) THERAPY IN AUSTRALIA FOR THE TREATMENT OF ADULTS WITH HYPERCHOLESTEROLAEMIA CLASSIFIED AS EITHER HIGH-RISK PRIMARY OR SECONDARY PREVENTION
Aug 11, 2026, 17:16 PM -
REAL-WORLD ADHERENCE TO RIBOCICLIB-BASED THERAPY IN HR+/HER2- ADVANCED BREAST CANCER: A RETROSPECTIVE COHORT STUDY IN ROMANIA
Aug 11, 2026, 17:16 PM -
HOW WILL MEMBER STATES USE IT? NATIONAL UPTAKE AND THE "DUE CONSIDERATION" OF JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
COMPARATIVE EFFECTIVENESS OF EHEALTH INTERVENTIONS ON QUALITY OF LIFE AND PSYCHOLOGICAL WELL-BEING IN PATIENTS WITH LUNG CANCER: A NETWORK META-ANALYSIS
Aug 11, 2026, 17:16 PM -
FROM MEDICAL WRITER TO MEDICAL EDITOR: REDEFINING THE ROLE OF HTA PROFESSIONALS IN THE AGE OF AI-ASSISTED DOCUMENT DEVELOPMENT
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF ADDING INTERMITTENT PNEUMATIC COMPRESSION TO PHARMACOLOGICAL THROMBOPROPHYLAXIS AFTER TOTAL HIP AND KNEE ARTHROPLASTY: A FRENCH HEALTH-SYSTEM ANALYSIS
Aug 11, 2026, 17:16 PM -
TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE UNITED STATES
Aug 11, 2026, 17:16 PM
